Elevance Health, Inc. (ELV) is positioned for growth with premium rate adjustments in the Health Benefits business, an expanding external pharmacy membership base and overall strength in the Carelon business. The BioPlus acquisition is expected to continue supporting the Carelon unit’s performance. Elevance — with a market cap of $111.6 billion — is one of the largest publicly traded health benefits companies in the United States. Courtesy of solid prospects, this currently Zacks Rank #3 (Hold) stock is wor ...